TipRanks
Third Age Health Services Limited (NZ:TAH)
:TAH
New Zealand Market
Want to see NZ:TAH full AI Analyst Report?

Third Age Health Services Limited (TAH) AI Stock Analysis

― Followers

Top Page

NZ:TAH

Third Age Health Services Limited

(TAH)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - Gpt-5.6Sol)
Rating:70Outperform
Price Target:
$5.00
Action:N/A
Date:10/05/26
The score is driven primarily by strengthening financial performance (higher profitability, improving leverage, and generally supportive cash flow), partially offset by technical weakness with the stock below key moving averages and slightly negative momentum. Valuation is reasonable with a moderate dividend yield, providing additional support but not enough to outweigh the near-term technical backdrop.
Positive Factors
Accelerating revenue and profitability
The combination of accelerating revenue and sharply higher net and operating margins indicates stronger operating leverage and improved execution. If maintained, this broader earnings base can support reinvestment, strengthen resilience, and provide a durable foundation for growth over the next several quarters.
Negative Factors
Sharp gross-margin compression
The steep decline in gross margin introduces a meaningful question about the durability of recent profitability gains. If cost pressure or adverse service mix persists, it could reduce operating leverage, constrain reinvestment capacity, and make future earnings more volatile despite strong reported growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Accelerating revenue and profitability
The combination of accelerating revenue and sharply higher net and operating margins indicates stronger operating leverage and improved execution. If maintained, this broader earnings base can support reinvestment, strengthen resilience, and provide a durable foundation for growth over the next several quarters.
Read all positive factors

Third Age Health Services Limited (TAH) vs. SPDR S&P 500 ETF (SPY)

Third Age Health Services Limited Business Overview & Revenue Model

Company Description
Third Age Health Services Limited, together with its subsidiaries, provides general practice health care services for older people living in retirement villages, private hospitals, and secure dementia units in New Zealand. The company offers aged ...

Third Age Health Services Limited Financial Statement Overview

Summary
Strong multi-year improvement with accelerating revenue growth and a large step-up in profitability (net margin ~3.9% in 2023 to ~12.6% in 2026; EBIT margin ~20.6% in 2026). Balance sheet leverage has improved materially (debt/equity down to ~0.66x in 2026), and cash flows generally support earnings (FCF ~98% of net income in 2026). Key risks are the sharp 2026 gross margin compression (~30.5% vs ~50%+ prior years) and historical variability in cash conversion and leverage sensitivity.
Income Statement
78
Positive
Balance Sheet
67
Positive
Cash Flow
74
Positive
BreakdownMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue22.49M19.08M15.15M11.22M5.90M
Gross Profit6.85M9.90M7.62M6.04M3.69M
EBITDA5.70M4.49M2.79M1.83M1.73M
Net Income2.83M2.34M1.40M439.00K1.17M
Balance Sheet
Total Assets13.21M10.96M9.72M10.04M4.86M
Cash, Cash Equivalents and Short-Term Investments2.90M2.59M1.70M1.35M1.12M
Total Debt3.35M3.57M4.05M5.38M1.09M
Total Liabilities7.70M6.99M6.80M7.50M2.16M
Stockholders Equity5.05M3.84M2.96M2.55M2.70M
Cash Flow
Free Cash Flow3.95M3.55M2.53M734.00K1.04M
Operating Cash Flow4.03M3.70M2.68M788.00K1.04M
Investing Cash Flow-1.54M-724.00K-149.00K-2.06M-970.00K
Financing Cash Flow-2.18M-2.08M-2.19M1.50M-775.00K

Third Age Health Services Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price―
Price Trends
50DMA
4.63
Negative
100DMA
4.61
Negative
200DMA
4.78
Negative
Market Momentum
MACD
-0.03
Positive
RSI
39.27
Neutral
STOCH
21.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NZ:TAH, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 4.63, equal to the 50-day MA of 4.63, and equal to the 200-day MA of 4.78, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 39.27 is Neutral, neither overbought nor oversold. The STOCH value of 21.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for NZ:TAH.

Third Age Health Services Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
70
Outperform
$45.49M16.07―3.60%17.86%20.79%
66
Neutral
$1.76B5.658.89%2.43%14.09%-18.30%
63
Neutral
$34.15M0.03――29.55%-11.97%
56
Neutral
$1.83B-10.88-4.17%3.15%11.86%72.99%
56
Neutral
$114.80M12.16―4.23%14.16%34.82%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
50
Neutral
$514.20M3,525.000.02%4.16%2.52%-99.52%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NZ:TAH
Third Age Health Services Limited
4.46
0.02
0.50%
NZ:OCA
Oceania Healthcare
0.70
>-0.01
-0.71%
NZ:RYM
Ryman Healthcare
1.80
-0.91
-33.52%
NZ:SUM
Summerset Group Holdings Limited
7.04
-3.88
-35.51%
NZ:PHL
Promisia Healthcare Limited
0.65
0.22
50.00%
NZ:RAD
Radius Residential Care Ltd
0.40
0.07
19.76%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 05, 2026